The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Expansion of HER2-CAR T cells after lymphodepletion and clinical responses in patients with advanced sarcoma.
 
Meenakshi Hegde
No Relationships to Disclose
 
Christopher C. DeRenzo
No Relationships to Disclose
 
Huimin Zhang
No Relationships to Disclose
 
Melinda Mata
No Relationships to Disclose
 
Claudia Gerken
No Relationships to Disclose
 
Ankita Shree
No Relationships to Disclose
 
Zhongzhen Yi
No Relationships to Disclose
 
Vita Brawley
No Relationships to Disclose
 
Olga Dakhova
No Relationships to Disclose
 
Meng-Fen Wu
No Relationships to Disclose
 
Hao Liu
No Relationships to Disclose
 
John Hicks
No Relationships to Disclose
 
Bambi Grilley
No Relationships to Disclose
 
Adrian P. Gee
No Relationships to Disclose
 
Cliona M. Rooney
No Relationships to Disclose
 
Malcolm K. Brenner
No Relationships to Disclose
 
Helen E. Heslop
No Relationships to Disclose
 
Winfried Wels
No Relationships to Disclose
 
Stephen Gottschalk
Consulting or Advisory Role - Abbvie; Celgene; Merrimack
Patents, Royalties, Other Intellectual Property - filed patent applications: 8 focused on cell therapy for cancer 1 focused on oncolytic viruses 1 focused on cancer gene therapy (Inst)
 
Nabil M. Ahmed
Consulting or Advisory Role - Adaptimmune
Patents, Royalties, Other Intellectual Property - Cell Medica